Coexistence of Copy Number Changes of Different Genes (INK4A, erbB-1, erbB-2, CMYC, CCND1 and ZNF217) in Urothelial Tumors
- 1 January 2005
- journal article
- Published by Springer Science and Business Media LLC in Tumor Biology
- Vol. 26 (2), 88-93
- https://doi.org/10.1159/000085815
Abstract
The aim of this study was to establish the frequency of combinatorial and separate copy number changes of INK4A (9p21), erbB-1 (7p11), erbB-2 (17q17-21), CMYC (8q24), CCND1 (11q13) and ZNF217 (20q13) in urothelial tumors; a tissue microarray of 159 urothelial bladder tumors was analyzed by fluorescence in situ hybridization. A total of 38 invasive tumors were successfully analyzed for all 6 loci. Normal gene copy numbers of all loci were established in 13 tumors (34.2%). In 25 tumors (65.8%), at least one aberration was found. Single abnormalities were detected in 16 tumors (64%), while double or higher abnormalities were found in 9 tumors (39%). The most frequent genetic change was deletion of INK4A (60% of aberrant tumors), followed by increased copy number changes of ZNF217 (36%), CCND1 (28%), CMYC (12%) and erbB-1 (4%). It was significantly more frequent in pT1 than in pT2-4 tumors and was predominantly found separately, while oncogene copy number increases were usually combined with another aberration and were not associated with the tumor stage. We concluded that INK4A loss is usually found as a single aberration in bladder cancer, which is more frequent in pT1 than in pT2-4 tumors. Overrepresentations of putative oncogenes are present in these two groups with similar frequency and are rarely found as single abnormality.Keywords
This publication has 18 references indexed in Scilit:
- Centrosome Hyperamplification Predicts Progression and Tumor Recurrence in Bladder CancerClinical Cancer Research, 2004
- HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?European Journal Of Cancer, 2004
- High‐throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancerThe Journal of Pathology, 2003
- High-Throughput Tissue Microarray Analysis of erbB-2 Gene Amplification in Urinary Bladder CancerUrologia Internationalis, 2003
- HER‐2 and TOP2A coamplification in urinary bladder cancerInternational Journal of Cancer, 2003
- Genetic Alterations of p16INK4a and p14ARF Genes in Human Bladder CancerJournal of Urology, 2003
- Patterns of Chromosomal Imbalances in Advanced Urinary Bladder Cancer Detected by Comparative Genomic HybridizationThe American Journal of Pathology, 1998
- Epidermal‐growth‐factor‐receptor expression is associated with rapid tumor proliferation in bladder cancerInternational Journal of Cancer, 1994
- p53 anderbB-2 protein overexpression are associated with early invasion and metastasis in bladder cancerVirchows Archiv, 1993
- EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURSThe Lancet, 1985